Strategies in Light 2018: EnOcean exhibits self-powered wireless Easyfit LED controls
Jan 25, 2018 13:01 pm UTC| Business
SALT LAKE CITY and LONG BEACH, Calif., Jan. 25, 2018 -- At Strategies in Light 2018 (Long Beach, February 13-15, 2018), EnOcean, the world leader in energy harvesting wireless technology, will present its comprehensive...
Semtech Sponsors The Things Network’s LoRaWAN Developer Conference
Jan 25, 2018 13:01 pm UTC| Business
CAMARILLO, Calif., Jan. 25, 2018 -- Semtech Corporation (Nasdaq:SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, today announced its silver sponsorship for...
Jan 25, 2018 13:01 pm UTC| Business
DALLAS, Jan. 25, 2018 -- RMG Networks Holding Corporation (NASDAQ:RMGN), or RMG, a global leader in technology-driven visual communications, announced a five-year, $460,000 contract with a large resort casino company...
Getaway Triples Capacity at Boston-Area Outpost With 29 New Cabins
Jan 25, 2018 13:01 pm UTC| Business
BOSTON, Jan. 25, 2018 -- Getaway, a company that designs and builds tiny cabins, places them in nature and rents them by the night to people looking to disconnect and recharge, has tripled the capacity of its...
Jan 25, 2018 13:01 pm UTC| Business
SAN DIEGO, CA, Jan. 25, 2018 -- SourcingLink.net Inc. (OTC Pink: SNET) is pleased to announce the completion of Phase I surface exploration on the Lac Fire Lithium property in James Bay, Quebec. Lac Fire Lithium...
Actinium Pharmaceuticals Issues Letter to Investors Providing Company Update and Outlook for 2018
Jan 25, 2018 13:01 pm UTC| Business
Strong finish to 2017 sets stage for series of value enhancing milestones in 2018 NEW YORK, Jan. 25, 2018 -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") announced today that it has...
Humanigen CEO to Present at NobleCon14, BIO CEO Investor Conferences
Jan 25, 2018 13:01 pm UTC| Business
BRISBANE, Calif., Jan. 25, 2018 -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and oncology treatments,...